Is glucagon‐like peptide‐1 fully protected by dipeptidyl peptidase 4 inhibitor administration in patients with type 2 diabetes?
ES Andersen, A Lund, JI Bagger… - Diabetes, Obesity …, 2018 - Wiley Online Library
Aims Glucagon‐like peptide‐1 (GLP‐1) is rapidly degraded by the enzyme dipeptidyl
peptidase 4 (DPP‐4), which exists in a soluble form in plasma and a membrane‐bound
form. Whether measurement of plasma DPP‐4 activity reflects total DPP‐4 activity, and …
peptidase 4 (DPP‐4), which exists in a soluble form in plasma and a membrane‐bound
form. Whether measurement of plasma DPP‐4 activity reflects total DPP‐4 activity, and …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com

没有评论:
发表评论